III.1 Tamoxifen and the uterus—the hysteroscopic approach

Yves Van Belle; R. Campo; Patrick Neven; X. De Muylder; G. Vanderick

doi:10.1016/s0959-8049(98)00098-7

III.1 Tamoxifen and the uterus—the hysteroscopic approach

Yves Van Belle, R. Campo, Patrick Neven, X. De Muylder, G. Vanderick

In: European Journal of Cancer · 1998 · vol. 34 , pp. S31–S32 · doi:10.1016/s0959-8049(98)00098-7 · W1989598808

article OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper describes hysteroscopic observations of the uterus in patients treated with tamoxifen, focusing on common findings and their implications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (4)

Endometrial lesions in patients undergoing tamoxifen therapy via openalex
Hysteroscopic follow-up during Tamoxifen treatment via openalex
TAMOXIFEN AND THE UTERUS AND ENDOMETRIUM via openalex
W2162141587 via openalex

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00

License: CC0 · commercial use OK

[1] TAMOXIFEN AND THE UTERUS AND ENDOMETRIUM 1989

[2] Endometrial lesions in patients undergoing tamoxifen therapy 1991

[3] Hysteroscopic follow-up during Tamoxifen treatment 1990